Dasatinib is an effective agent in the treatment of bcr-abl positive acute lymphoblastic leukemia and chronic myeloid leukemia cases. Various skin reactions may occur when tyrosine kinase inhibitors are used. The severity of side effects increases in phototoxic reactions with sunlight. https://pwmhkuzhaojbw.collectblogs.com/79712311/abundancer-a-novel-method-for-estimating-wildlife-abundance-based-on-distance-sampling-and-species-distribution-models